TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Special Report on the American Legacy Foundation: As Legacy seeks new funding, critics fear symbiosis with Big Tobacco. Legacy, NCI, C-Change relationship could open door to industry influence, lawyer says. October 29, 2004
TCL Archive Varmus Pledges No Funding Gap for NCORP, Blames Snafu On “Unclear Communication” April 11, 2014
